Navigation Links
Transposagen's piggyBac™ Vectors to be Distributed by System Biosciences
Date:5/11/2011

LEXINGTON, Ky., and MOUNTAIN VIEW, Calif., May 11, 2011 /PRNewswire/ -- Transposagen Biopharmaceuticals, Inc. (Transposagen) and System Biosciences (SBI), both leaders in genetic modification technology, have announced a non-exclusive marketing and distribution agreement between the two biotechnology companies involving Transposagen's piggyBac™ technology.

The piggyBac Genetic Modification System enables researchers to:

  • Alter the genomes of numerous animal species with a simple transfection
  • Reprogram somatic cells into induced pluripotent stem (iPS) cells
  • Perform highly efficient and cost-effective non-viral gene delivery
  • Reverse genomic modifications with footprint-free transposon removal

  • The piggyBac DNA transposon technology is already being utilized in multiple research areas, such as gene therapy, regenerative medicine, cell line engineering, and animal model creation. "We are excited to add the world's most efficient and cost-effective non-viral reprogramming technology to our already impressive catalog of stem cell and microRNA research reagents," said Dr. Travis Antes, the Director of Product Development at SBI.  

    (Logo: http://photos.prnewswire.com/prnh/20110511/CL00173LOGO)

    Researchers in academia and the pharmaceutical and biotechnology industries can now purchase piggyBac™ vectors produced with SBI's high standards of manufacturing and quality control. Transposagen's piggyBac™ technology will be paired with SBI's existing leading-edge technologies to further broaden the utility of piggyBac™. SBI will also use piggyBac™ in custom vectors and cell lines for customers. Furthermore, Transposagen and SBI have agreed to collaborate in the production of custom transgenic rats. The collaboration will combine SBI's genomic tools and expertise with Transposagen's piggyBac and rat spermatogonial stem cell technology. Researchers will now have access to specialized transgenic rats incorporating SBI's reagents, such as species-specific RNAi, MicroRNAs or anti-MicroRNAs. Rat models with inducible gene expression can also be produced using SBI's SparQ™ cumate switch system, the first inducible system that can be induced with a small molecule that can readily cross the blood-brain and blood-testis barriers.  "The combination of Transposagen and SBI's innovative technologies will now allow researchers to make sophisticated transgenic rat models that may mimic human diseases better than in the past," said Eric Ostertag, President and CEO of Transposagen.About Transposagen Biopharmaceuticals:Transposagen Biopharmaceuticals, Inc., a Lexington, KY-based company, is the worldwide leader in the creation of unique genetically modified rat models.  The company's signature products, TKO™ Knockout Rat Models and TGEM™ Rat Models, mimic human diseases and are used for drug discovery and development research. The company also creates custom transgenic rat models and custom knockout rat models to customer specifications. For more information or to request a custom rat model, visit www.transposagenbio.com.

    About System Biosciences (SBI):System Biosciences (SBI) specializes in developing unique, innovative technologies to provide researchers with the tools to investigate and understand genomic and proteomic function. SBI offers solutions for Lentiviral, Minicircle and piggyBac-mediated gene delivery and knockdown, high-throughput RNAi screens and products for Stem Cell and MicroRNA research. For more information, visit www.systembio.com.Transposagen Contact:System Biosciences Contact:Craig Morley

    Jake Lesnik201 East Main St. Suite 1405

    265 North Whisman Rd.Lexington, KY 40507

    Mountain View, CA 94043314-602-1993

    650-968-2200cmorley@transposagenbio.comjlesnik@systembio.comwww.transposagenbio.com

    www.systembio.com
    '/>"/>

    SOURCE Transposagen Biopharmaceuticals, Inc.; System Biosciences
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. BD and Diagenode Collaborate to Expand Infectious Disease Menu on the BD MAX™ System
    2. Image Sensing Systems Announces First Quarter Financial Results
    3. UCLA scientists discover new way to wake up the immune system using nano vaults to deliver drugs
    4. Smart Systems Week in Helsinki June 14-17, 2011
    5. Announcement - Clontech Laboratories, Inc. Releases the iDimerize™ Cell Signaling and Expression Systems
    6. Tomophase Announces First Sale of Its OCT Imaging System (OCTIS™) for Research Use to the University of Texas
    7. Conflict of Interest Management System Selected by Henry Ford Health System
    8. WaferGen and NuGEN Announce Agreement to Co-Develop Integrated Workflows Using SmartChip System and SPIA® for Single Cell Analysis, FFPE and Next Generation Sequencing
    9. Global HPLC Systems & Accessories Industry
    10. New Drug Delivery System to Improve Cancer Treatment
    11. Calipers Microfluidic Technologies Enable 510(k) Approved Multiplexed Immunoassay System for Liver Cancer Risk Assessment
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
    (Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
    (Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
    (Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
    Breaking Biology Technology:
    (Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
    (Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
    (Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
    Breaking Biology News(10 mins):